IGWM
TCON

ICA Group Wealth Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

ICA Group Wealth Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$29 – 1305
2023
Q2 		$29 Hold
5
– – ﹤0.01% 1329
2023
Q1 		$189 Hold
5
– – ﹤0.01% 1240
2022
Q4 		$168 Buy
+5
New +$151 ﹤0.01% 1281

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

ICA Group Wealth Management's TCON Position: Q3 2023 in Review

ICA Group Wealth Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2023, closing a stake of 5 shares — an estimated $29 sold.

ICA Group Wealth Management first reported a position in TCON in Q4 2022 and held it in 3 quarters. The position peaked at $189 in Q1 2023. 21 funds tracked by Wall St. Rank hold TCON as of Q3 2023.

  • ICA Group Wealth Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • ICA Group Wealth Management sold 5 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $29.
  • ICA Group Wealth Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • ICA Group Wealth Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $189 in Q1 2023.
  • 21 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on ICA Group Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.